Induction and augmentation of labor in hypertensive patients with intravenous prostaglandin E2.
Labor was successfully induced or stimulated with intravenous Prostaglandin E2 (0.1-2.0 microgram/min) in a group of twenty-nine hypertensive gravidae at 36-41 weeks' gestation. No adverse maternal or perinatal effects of the drug were recorded.
D005260:Female; D005318:Fetal Heart / Q000187:drug effects; D005323:Fetal Monitoring; D006801:Humans; D006973:Hypertension; D007231:Infant, Newborn; D007751:Labor, Induced; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D011458:Prostaglandins E / Q000008:administration & dosage*; D014590:Uterine Contraction / Q000187:drug effects*
D011458:Prostaglandins E